Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); WORLD Phase 3 Data Suggest 50-70% Prevalence
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Amicus Therapeutics (NASDAQ: FOLD) price target of $10.00
Analyst, Ritu Baral, said, "Reiterate rating and price target on migalastat potentially positive pivotal Fabry monotx data Q3/12, mono and combotx market potential. We think Q3/12 pivotal migalastat (fka Amigal) Fabry monotx ‘011’ trial data will be a strong positive, transformational catalyst. We think ‘011 has a high chance of success on Phase 2 precedent, patient enrichment and better quantification technology. We also expect good top-line Phase 2 proof of concept AT2220/ERT Pompe combo data in H1/12 similar to today’s positive Fabry data."
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $6.48 yesterday.
Analyst, Ritu Baral, said, "Reiterate rating and price target on migalastat potentially positive pivotal Fabry monotx data Q3/12, mono and combotx market potential. We think Q3/12 pivotal migalastat (fka Amigal) Fabry monotx ‘011’ trial data will be a strong positive, transformational catalyst. We think ‘011 has a high chance of success on Phase 2 precedent, patient enrichment and better quantification technology. We also expect good top-line Phase 2 proof of concept AT2220/ERT Pompe combo data in H1/12 similar to today’s positive Fabry data."
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $6.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- Cummins (CMI) PT Lowered to $675 at Jefferies
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
